Effect of crystal form on in vivo topical anti-inflammatory activity of corticosteroids

Archives of Pharmacal Research

Volumn 25, Issue 4, 2002, Pages 556-559

  Sohn, Young Taek ^a   Kim, Sun Young ^a  

^a Duksung Women's Univerisity   (South Korea)

Author keywords

Corticosteroids; Crystal Form; Topical anti inflammation

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; STEROID;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ANTAGONISM; EDEMA; EXTERNAL EAR; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; PATHOLOGY; SUSPENSION; TOPICAL DRUG ADMINISTRATION; X RAY CRYSTALLOGRAPHY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; EAR, EXTERNAL; EDEMA; MALE; MICE; MICE, INBRED ICR; STEROIDS; SUSPENSIONS;

EID: 0036690384     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02976618     Document Type: Article

References (14)

1. Idson, B., Vehicle effects in percutaneous absorption. Drug Metab. Rev., 14, 207-222 (1983).
2. Massimo, F. and Giovanni, P., Corticosteroid dermal delivery with skin-lipid liposomes. J. Controlled Rel., 44, 141-151 (1997).
3. Buyuktimkin, N., Buyuktimkin, S. and Rytting, J. H., Chemical means of transdermal drug permeation enhancement. In Ghosh, T. K., Pfister, W. R. and Yum, S. I. (Eds.). Transdermal and topical drug delivery systems, Interpharm Press Inc., Buffalo Grove, Illinois, pp.357, (1997).
4. Green, P. G., Flanagan, M., Shroot, B. and Guy, R. H., Iontophoretic Drug Delivery. In Walters, K. A. and Hadgraft, J. (Eds.). Pharmaceutical skin penetration enhancement, Marcel Decker, New York, pp.331, (1993).
5. Prausnitz, M. R., Pliquett, U., Langer, R. and Weaver, J. C., Rapid temporal control of transdermal drug delivery by electroporation. Pharm. Res., 11, 1834-1837 (1994).
6. Murphy, T. M. and Hardgraft, J. A., Physicochemical interpretation of phonoporesis in skin penetration enhancement. In Scott, R. C., Guy, R. H. and Hardgraft, J. (Eds.). Prediction percutaneous penetration : methods, measurements, modeling, IBC Technical Service Ltd., London, pp 333, (1990).
7. Watson, W. S. and Finlay, A. Y., The effect of the vehicle formulation on the stratum corneum penetration characteristics of clobetasol 17-propionate. Br. J. Dermatol., 118, 523-530 (1988).
8. Bird, J., Kim, H. P. and Lee, H. J., Anti-inflammatory activity of esters of steroid 21-oic acids. Steroids, 47, 35-40 (1986).
9. Kim, H. K., Namgoong, S. Y. and Kim, H. P., Anti-inflammatory activity of flavonoids:Mouse ear edema inhibition. Arch. Pharm. Res., 16, 18-24 (1993).
10. Mesley, R. J., The infra-red spectra of certain steroids and dissolution rate of their tablets. Spectrochim. Acta, 22, 889-917 (1966).
11. Gao, C. K. and Zahng, R. H., Polymorphic forms of certain steroids and dissolution rate of their tablets. Pharm. Ind., 18, 301-306 (1987).
12. De Maury; G., Chauvet; A., Terol, A. and Masse, J., Etude thermoanalytique de quelques steroids IV. Prednisolone et derives. Thermochimica Acta, 97, 127-142 (1986).
13. Veiga, M. D., Cadorniga, R., Fonseca, I. and Garcia-Blanco, S., Polymorphism characterization of prednisolone: spectrometric and diffractometric study. Il Farmaco Ed. Pr., 42, 93-102 (1987).
14. Guillory, J. K., Heat of transition of methylprednisolone and sulfathiazole by a differential thermal analysis method. J. Pharm. Sci., 56, 72-76 (1967).